002022 Shanghai Kehua Bio-engineering
WatchlistShanghai Kehua Bio-engineering News
Kehua Biotech: Announcement on the Appointment of the Company\'s Vice President
Kehua Biotech: Semi-annual summary of non-operating capital usage and other related capital transactions
Kehua Biotech: Special system for managing the company\'s shares and changes held by directors, supervisors and senior management (revised in August 2023)
Kehua Biotech: 2023 Semi-Annual Financial Report
Kehua Biotech: Announcement on the signing of quadripartite and five-party regulatory agreements to raise capital
Kehua Biotech: Announcement on the 2023 Interest Payment of Convertible Corporate Bonds
Kehua Biotech: Legal Opinion of Guohao Law Firm (Shanghai) on the 2023 Second Extraordinary General Meeting of Shareholders of Shanghai Kehua Bioengineering Co., Ltd.
Kehua Biotech: Announcement of Resolutions of the Second Extraordinary General Meeting of Shareholders in 2023
Kehua Biotech: Announcement on the signing of a quadripartite regulatory agreement to raise capital
Kehua Biotech: Announcement on the convertible debt-for-equity swaps situation in the second quarter of 2023
Kehua Biotech: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2023
Kehua Biotech: Announcement on Independent Directors Obtaining Independent Director Qualification Certificates
Kehua Biotech: Announcement on the Board of Directors and the Board of Supervisors Finalizing Elections and Appointing Senior Management, Securities Affairs Representatives, and Audit Department Heads
Kehua Biotech: Announcement on the revision of the “Articles of Association”
Kehua Biotech: “Articles of Association” (revised in June 2023)
Kehua Biotech: Legal Opinion of Guohao Law Firm (Shanghai) on the 2023 First Extraordinary General Meeting of Shareholders of Shanghai Kehua Bioengineering Co., Ltd.
Kehua Biotech: Rules of Procedure of the Board of Directors (revised in June 2023)
Kehua Biotech: Announcement on Purchasing High Liability Insurance for Directors and Supervisors
Kehua Biotech: Announcement of Resolutions of the 2023 First Extraordinary General Meeting of Shareholders
Kehua Biotech: Announcement on not revising the “Kehua Convertible Bonds” conversion price downward